NASDAQ · Health care

Omada Health, Inc. (OMDA)

Omada Health, Inc. brought in $309.8M of revenue over the twelve months to June 30, 2026. Net income was $4.3M, a net margin of 1.4%. Operating cash flow minus capital spending left $16.9M of free cash flow in fiscal 2025. At June 30, 2026 it held $221.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 7, 2026.

Price

$19.66

-0.30% on the day · September 25, 2026

52-week range $10.28 to $26.92

Market cap

$1.2B

Revenue (last 12 months)

$309.8M

Net margin

1.4%

What Omada Health, Inc. does

Omada Health, Inc. is registered with the SEC under industry code SIC 8000 (Services-Health Services). Its shares trade on NASDAQ under the ticker OMDA.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	$260.2M	-$12M	-$12.8M	-$0.35	$16.9M
2025	$169.8M	-$43.7M	-$47.1M	-$6.11	-$34.8M
2023	$122.8M	-$66M	-$67.5M	-$9.52	-$50.2M

Next report expected around November 5, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 6, 2025. Not a date the company has announced. See the report calendar

Where OMDA ranks in Health care

Revenue$260.2M

#234 of 523 in Health care · Top 45%

Revenue growth+53.2%

#80 of 437 in Health care · Top 18%

Net margin-4.9%

#217 of 447 in Health care · Top 48%

Free cash flow margin6.5%

#144 of 408 in Health care · Top 35%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Omada Health, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

August 14, 2026
Passive stake changed SCHEDULE 13G/A
August 14, 2026
Passive stake (5% or more) SCHEDULE 13G
August 7, 2026
Quarterly report 10-Q · period to June 30, 2026
August 6, 2026
Quarterly results 8-K
June 23, 2026
Passive stake (5% or more) SCHEDULE 13G
June 16, 2026
Shareholder vote results 8-K
May 15, 2026
Passive stake changed SCHEDULE 13G/A
May 15, 2026
Passive stake (5% or more) SCHEDULE 13G
May 8, 2026
Quarterly report 10-Q · period to March 31, 2026
May 7, 2026
Quarterly results 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 14, 2026. Insider transactions on SEC

What is OMDA worth? A DCF from its reported cash flow

Insider trades

What the people running Omada Health, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $1.4M worth of shares in the last 90 days and bought none on the open market. All of the selling was pre-planned under Rule 10b5-1 trading plans.

Bought (open market)

last 90 days

Sold

$1.4M

last 90 days

Net sold

58,538

$1.4M

Date	Insider	What	Shares	Price	Value	Filing
September 10, 2026	Shao Wei-LiPresident	Soldpre-planned (10b5-1)	3,636	$21.78	$79.2K	Form 4
September 10, 2026	Shao Wei-LiPresident	Soldpre-planned (10b5-1)	400	$22.53	$9K	Form 4
September 10, 2026	Cook Steven L.Chief Financial Officer	Soldpre-planned (10b5-1)	6,200	$21.80	$135.1K	Form 4
September 10, 2026	Cook Steven L.Chief Financial Officer	Soldpre-planned (10b5-1)	600	$22.52	$13.5K	Form 4
September 10, 2026	Duffy Sean P.Chief Executive Officer, Director	Soldpre-planned (10b5-1)	13,560	$21.80	$295.6K	Form 4
September 10, 2026	Duffy Sean P.Chief Executive Officer, Director	Soldpre-planned (10b5-1)	1,400	$22.59	$31.6K	Form 4
September 9, 2026	Gracey CraigChief Accounting Officer	Soldpre-planned (10b5-1)	644	$21.73	$14K	Form 4
September 5, 2026	Duffy Sean P.Chief Executive Officer, Director	Shares withheld for tax	4,422	$22.77	$100.7K	Form 4
September 5, 2026	Cook Steven L.Chief Financial Officer	Shares withheld for tax	2,010	$22.77	$45.8K	Form 4
September 5, 2026	Shao Wei-LiPresident	Shares withheld for tax	1,843	$22.77	$42K	Form 4
September 1, 2026	Duffy Sean P.Chief Executive Officer, Director	Exercised options	12,944	$5.82	$75.3K	Form 4
September 1, 2026	Duffy Sean P.Chief Executive Officer, Director	Exercised options	4,314	$8.28	$35.7K	Form 4
September 1, 2026	Duffy Sean P.Chief Executive Officer, Director	Exercised options	4,314	$9.18	$39.6K	Form 4
September 1, 2026	Duffy Sean P.Chief Executive Officer, Director	Soldpre-planned (10b5-1)	7,344	$23.12	$169.8K	Form 4
September 1, 2026	Duffy Sean P.Chief Executive Officer, Director	Soldpre-planned (10b5-1)	5,600	$24.27	$135.9K	Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about OMDA

What does Omada Health, Inc. do?

Omada Health, Inc. is registered with the SEC under industry code SIC 8000 (Services-Health Services). Its shares trade on NASDAQ under the ticker OMDA.

Is Omada Health, Inc. profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $4.3M on revenue of $309.8M, a net margin of 1.4%.

How much revenue does Omada Health, Inc. make?

Over the twelve months to June 30, 2026 Omada Health, Inc. reported revenue of $309.8M.

When did Omada Health, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 7, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 14, 2026.

Similar companies

PRVA

Privia Health Group, Inc.

PIII

P3 Health Partners Inc.

LFST

LifeStance Health Group, Inc.

INNV

InnovAge Holding Corp.

PNTG

Pennant Group, Inc.

USPH

U S Physical Therapy Inc

Compare OMDA with

Compare OMDA with any company

Follow OMDA

Get an email when Omada Health, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow OMDA: get an email when it files

Where the numbers come from

Financial figures are the values Omada Health, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.